Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection

CMAJ. Canadian Medical Association Journal

Volumn 165, Issue 7, 2001, Pages 889-895

  Patrick, D M ^a   Tyndall, M W ^a   Cornelisse, P G A ^a   Li, K ^a   Sherlock, C H ^a   Rekart, M L ^a   Strathdee, S A ^a   Currie, S L ^a   Schechter, M T ^a   O'Shaughnessy, M V ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COCAINE;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BEHAVIOR; CANADA; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DENSITY; DISEASE ASSOCIATION; DRUG USE; FEMALE; FOLLOW UP; GENDER; HEALTH CARE UTILIZATION; HEALTH STATUS; HEPATITIS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MODEL; QUESTIONNAIRE; SEROCONVERSION; SEROLOGY; STATISTICS; VIRUS TRANSMISSION;

EID: 0035661177     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver
2. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study
3. Do needle exchange programmes increase the spread of HIV among injection drug users? An investigation of the Vancouver outbreak
4. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam
5. Hepatitis virus infection and liver disease in injecting drug users who died suddenly
6. Hepatitis C virus infection in Italian intravenous drug users: Epidemiological and clinical aspects
7. Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994
8. Sexual behaviour and multiple infections in drug abusers
9. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection
10. Hepatitis C virus antibodies in acute icteric and chronic non-A, non-B hepatitis
11. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland
12. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users
13. Human immunodeficiency virus seroprevalence and risk behaviors in patients attending sexually transmitted disease clinics in Alberta
14. High prevalence of hepatitis C virus infection in Belgian intravenous drug users and potential role of the "cotton-filter" in transmission: The GEMT study
15. Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan
16. Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995
17. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain
18. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations
19. Methadone maintenance and hepatitis C virus infection among injecting drug users
20. The multiperson use of non-syringe injection equipment and risk of hepatitis C infection in a cohort of young adult injection drug users, Chicago 1997-1999
21. Syringe exchange and risk of infection with hepatitis B and C viruses
22. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland
23. The importance of preventing hepatitis C virus infection among injection drug users in the United States
24. Comparison of 5 commercial EIA kits and 2 immunoblot kits for detection of hepatitis C antibody [oral presentation]
25. Hepatitis C virus transmission dynamics in injection drug users
26. Explosive HIV epidemics in injection drug users - What are the causes and controls?
27. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T- lymphotropic viruses
28. Correlates of hepatitis C virus infection drug users
29. The force of numbers: Why hepatitis C is spreading among Australian injecting drug users while HIV is not
30. Hepatitis C virus: Epidemiology and transmission
31. Frontloading: A risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin
32. Lack of evidence for the heterosexual transmission of hepatitis C
33. Heterosexual transmission of hepatitis C virus and the possible role of coexistent human immunodeficiency virus infection in the index case. A multicentre study of 423 pairings
34. Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin
35. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection
36. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study
37. HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary
38. HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profile
39. Talc in the liver of patients with chronic hepatitis C infection
40. Incidence of hepatitis C in patients requiring orthopaedic surgery
41. A computer model of the spread of hepatitis C virus among injecting drug users